Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2744989 | Anesthesiology Clinics | 2008 | 19 Pages |
Abstract
Cardiac surgeons are increasingly faced with a more complex patient who has developed a pattern of diffuse coronary artery disease that cannot be completely revascularized by CAGB alone. Considering the increased operative and long-term cardiac risks predicted by incomplete revascularization, and the documented operative and long-term benefits associated with sole therapy and adjunctive TMR in randomized patients with diffuse coronary artery disease, increased use of sole therapy and adjunctive TMR therapy is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Keith B. MD, James MD, A. Michael MD, R. Scott MD, Emmanuel MD, Alexander F. MD, George L. MD, Michelle MD,